Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer

NCT02820961 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Estrogen Receptor Positive Breast Cancer

Interventions

DRUG: entinostat
DRUG: exemestane

Sponsor

Syndax Pharmaceuticals